Regulators increasingly expect explicit acknowledgment of such uncertainty and clear plans to resolve it through biomarker-driven early-phase studies, rather than relying solely on associative epidemiology
As a pharmacist, I can appreciate the excitement in the rise in oral semaglutide, since it is an easier route than injectables, says Melinda Lee, a pharmacist who runs the pharmaceutical packaging company Parcel Health as well as a GLP-1 drug availability database
Many patients experience rapid initial loss (weeks 2-8), a plateau phase (weeks 8-16), then resumption of gradual loss as tolerance stabilizes
This is one reason why microdosing GLP-1 for menopause has gained interest
The Phase 3 TRIUMPH program enrolls over 5,800 people specifically to find those rare events
Stress, aging, health conditions, and lifestyle factors can all impact desire, performance, and satisfaction